Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company that develops and acquires products to address unmet medical needs. It has a diversified portfolio that includes both commercial products and candidates in various stages of development, including those in Phase III clinical trials. The company focuses on identifying and pursuing business opportunities that align with its existing product offerings, including potential mergers and acquisitions.
